medicine-technology-1/otcbb-vhgi-updates-shareholders-on-status-of-healthcare-asset-sale-and-treasure-gulch-gold-mine-development-strategy-6051-2/;/a><br

Breaking Biology Technology:Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective 2 Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective 3 Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective 4 Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective 5 Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective 6 Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective 7 Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective 8 Vivakor Announces Mechanics of Dividend Distribution 2 Vivakor Announces Mechanics of Dividend Distribution 3 HemaQuest Pharmaceuticals Presents Promising Results in Sickle Cell Disease and Beta Thalassemia 2 HemaQuest Pharmaceuticals Presents Promising Results in Sickle Cell Disease and Beta Thalassemia 3 New technology could boost disease detection tests' speed and sensitivity 2

[0] Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective [0] Vivakor Announces Mechanics of Dividend Distribution [0] HemaQuest Pharmaceuticals Presents Promising Results in Sickle Cell Disease and Beta Thalassemia [0] New technology could boost disease detection tests' speed and sensitivity

Breaking Medicine Technology:Ascension Orthopedics Hires Key Senior Executives 2 Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2 Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3 Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4 Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5 Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6 Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2 Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3 Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4 Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5 Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6 DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 59225 1 DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 59225 2 DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 59225 3 Gene Data Tool Advances Prospects for Personalized Medicine 59221 1 Gene Data Tool Advances Prospects for Personalized Medicine 59221 2 Gene Data Tool Advances Prospects for Personalized Medicine 59221 3 Prize4Life Marks One Year Anniversary of Avi Kremer ALS Treatment Prize 59217 1 Prize4Life Marks One Year Anniversary of Avi Kremer ALS Treatment Prize 59217 2 Prize4Life Marks One Year Anniversary of Avi Kremer ALS Treatment Prize 59217 3

[0] Ascension Orthopedics Hires Key Senior Executives [0] Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase [0] Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium